Wikidata

(Q34002037)

English

Open-label phase II study evaluating the efficacy and safety of two doses of pertuzumab in castrate chemotherapy-naive patients with hormone-refractory prostate cancer.

scientific article

In more languages

Statements

title
Open-label phase II study evaluating the efficacy and safety of two doses of pertuzumab in castrate chemotherapy-naive patients with hormone-refractory prostate cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17235043
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235043%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34002037&oldid=1869082997"